Home › Funds › Ikarian Capital, LLC › CAPR
Ikarian Capital, LLC position in CAPR
CAPRICOR THERAPEUTICS INC COM NEW · Health Care
Ikarian Capital, LLC reported holding 350,000 shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$8.4M, representing 1.35% of its reported portfolio and ranking #22 among its reported holdings. Ikarian Capital, LLC has disclosed CAPR holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's CAPR position evolved
Ikarian Capital, LLC first disclosed a stake in CAPR in Q3 2024 at 300,000 shares (US$4.6M). The position peaked in Q4 2025 at 578,015 shares, worth US$16.7M. Across 8 filings, Ikarian Capital, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 350,000 shares valued at US$8.4M. Notable position changes include a 75% increase in Q2 2025 (shares fell 27% over the following quarter), a 86% trim in Q3 2025 (shares rose 300% over the following quarter), a 478% increase in Q4 2025 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 300.00K | $4.56M | New |
| Q4 2024 | 300.00K | $4.14M | Hold |
| Q1 2025 | 400.00K | $3.80M | Add |
| Q2 2025 | 700.00K | $6.95M | Add |
| Q3 2025 | 100.00K | $721.00K | Reduce |
| Q4 2025 | 578.01K | $16.68M | Add |
| Q1 2026 | 350.00K | $10.64M | Reduce |
| Q2 2026 | 350.00K | $8.43M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAPR and 13F data
CAPR (CAPRICOR THERAPEUTICS INC COM NEW) is a Health Care company. 64 other funds we track also report a position in CAPR — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$98.7M), MONTANOVA CAPITAL, LLC (US$98.6M), RA CAPITAL MANAGEMENT, L.P. (US$36.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAPR
- TANG CAPITAL MANAGEMENT LLC 4.10M sh · $98.73M · Q2 2026
- MONTANOVA CAPITAL, LLC 4.09M sh · $98.55M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.51M sh · $36.31M · Q2 2026
- Boxer Capital Management, LLC 1.40M sh · $33.60M · Q2 2026
- Soleus Capital Management, L.P. 761.74K sh · $18.34M · Q2 2026
- DG Capital Management, LLC 611.60K sh · $14.73M · Q2 2026
- Jones Hill Capital LP 420.75K sh · $10.13M · Q2 2026
- DIADEMA PARTNERS LP 329.30K sh · $7.93M · Q2 2026
- Palo Alto Investors LP 229.76K sh · $5.53M · Q2 2026
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held CAPR?
Ikarian Capital, LLC has disclosed CAPR holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is Ikarian Capital, LLC's current position in CAPR?
As of Q2 2026, Ikarian Capital, LLC holds 350.00K shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW), valued at $8.43M, representing 1.35% of its reported portfolio and ranking #22.
Has Ikarian Capital, LLC been buying or selling CAPR?
In the latest 13F filing (Q2 2026), Ikarian Capital, LLC held unchanged its position in CAPR. The position peaked in Q4 2025 at 578.01K shares.
Which other funds hold CAPR?
Other major institutional holders of CAPR include TANG CAPITAL MANAGEMENT LLC, MONTANOVA CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.